AMP Capital Investors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-529,695
| Closed | -$23M | – | 317 |
|
|
2021
Q3 | $23M | Sell |
529,695
-105,967
| -17% | -$4.69M | 0.13% | 185 |
|
|
2021
Q2 | $27.2M | Sell |
635,662
-4,571
| -0.7% | -$192K | 0.13% | 181 |
|
|
2021
Q1 | $24.8M | Sell |
640,233
-18,069
| -3% | -$684K | 0.12% | 195 |
|
|
2020
Q4 | $23.4M | Buy |
658,302
+9,027
| +1% | +$325K | 0.13% | 200 |
|
|
2020
Q3 | $24.5M | Sell |
649,275
-30,834
| -5% | -$1.19M | 0.15% | 163 |
|
|
2020
Q2 | $23.6M | Buy |
680,109
+16,597
| +3% | +$598K | 0.15% | 163 |
|
|
2020
Q1 | $21M | Sell |
663,512
-76,496
| -10% | -$2.99M | 0.15% | 158 |
|
|
2019
Q4 | $33.3M | Sell |
740,008
-50,362
| -6% | -$2.11M | 0.18% | 141 |
|
|
2019
Q3 | $31.9M | Sell |
790,370
-57,922
| -7% | -$2.45M | 0.18% | 143 |
|
|
2019
Q2 | $35.6M | Buy |
848,292
+14,269
| +2% | +$549K | 0.2% | 125 |
|
|
2019
Q1 | $31.6M | Buy |
834,023
+80,553
| +11% | +$3.08M | 0.18% | 144 |
|
|
2018
Q4 | $26.1M | Buy |
753,470
+171,724
| +30% | +$6.23M | 0.17% | 156 |
|
|
2018
Q3 | $22.3M | Buy |
581,746
+64,977
| +13% | +$2.27M | 0.12% | 207 |
|
|
2018
Q2 | $16.9M | Sell |
516,769
-18,925
| -4% | -$571K | 0.09% | 245 |
|
|
2018
Q1 | $14.3M | Buy |
535,694
+20,842
| +4% | +$566K | 0.08% | 277 |
|
|
2017
Q4 | $12.8M | Sell |
514,852
-104,301
| -17% | -$2.88M | 0.07% | 317 |
|
|
2017
Q3 | $18.1M | Sell |
619,153
-87,338
| -12% | -$2.41M | 0.1% | 221 |
|
|
2017
Q2 | $19.7M | Sell |
706,491
-140,861
| -17% | -$3.74M | 0.12% | 199 |
|
|
2017
Q1 | $20.7M | Sell |
847,352
-57,105
| -6% | -$1.39M | 0.12% | 194 |
|
|
2016
Q4 | $19.6M | Buy |
904,457
+112,936
| +14% | +$2.46M | 0.12% | 204 |
|
|
2016
Q3 | $18.4M | Buy |
791,521
+248,368
| +46% | +$5.92M | 0.11% | 207 |
|
|
2016
Q2 | $12.5M | Sell |
543,153
-24,200
| -4% | -$524K | 0.08% | 257 |
|
|
2016
Q1 | $10.7M | Buy |
567,353
+13,400
| +2% | +$235K | 0.07% | 285 |
|
|
2015
Q4 | $10.3M | Sell |
553,953
-21,146
| -4% | -$379K | 0.07% | 309 |
|
|
2015
Q3 | $9.2M | Buy |
575,099
+59,701
| +12% | +$1.02M | 0.07% | 307 |
|
|
2015
Q2 | $9.18M | Buy |
515,398
+44,481
| +9% | +$795K | 0.06% | 334 |
|
|
2015
Q1 | $8.51M | Sell |
470,917
-108,128
| -19% | -$1.71M | 0.05% | 378 |
|
|
2014
Q4 | $7.74M | Sell |
579,045
-160,190
| -22% | -$2.05M | 0.05% | 405 |
|
|
2014
Q3 | $8.81M | Sell |
739,235
-561,800
| -43% | -$7.07M | 0.06% | 383 |
|
|
2014
Q2 | $16.6M | Sell |
1,301,035
-599,361
| -32% | -$7.79M | 0.1% | 232 |
|
|
2014
Q1 | $25.1M | Buy |
1,900,396
+12,457
| +0.7% | +$164K | 0.17% | 147 |
|
|
2013
Q4 | $22.7M | Buy |
1,887,939
+345,638
| +22% | +$4.08M | 0.16% | 161 |
|
|
2013
Q3 | $17.8M | Sell |
1,542,301
-62,558
| -4% | -$677K | 0.14% | 177 |
|
|
2013
Q2 | $14.8M | Buy |
+1,604,859
| New | +$13.6M | 0.11% | 205 |
|
Other funds holding BSX
BG
AMP Capital Investors's BSX Position: Q4 2021 in Review
AMP Capital Investors sold out of Boston Scientific (BSX) in Q4 2021, closing a stake of 529,695 shares — an estimated $23M sold.
AMP Capital Investors first reported a position in BSX in Q2 2013 and held it in 34 quarters. The position peaked at $35.6M in Q2 2019. 889 funds tracked by Wall St. Rank hold BSX as of Q4 2021.
- AMP Capital Investors reported no remaining Boston Scientific position as of Q4 2021 after selling out during the quarter.
- AMP Capital Investors sold 529,695 Boston Scientific shares in Q4 2021, an estimated $23M.
- AMP Capital Investors first reported a position in Boston Scientific in Q2 2013 and held it in 34 quarters.
- AMP Capital Investors's Boston Scientific position peaked at $35.6M in Q2 2019.
- 889 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2021.
Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.